Vybrat velikost
| Vám/Skladová položka | Dostupnost | Cena |
|---|---|---|
25 μL | Obraťte se na zákaznický servis a vyžádejte si informaci o dostupnosti. | 5 370,00 Kč |
4 x 25 μL | Obraťte se na zákaznický servis a vyžádejte si informaci o dostupnosti. | 10 900,00 Kč |
O této položce
5 370,00 Kč
biological source
mouse
Quality Segment
recombinant
expressed in HEK 293 cells
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
A1, recombinant monoclonal
description
recombinant, expressed in HEK 293 cells
product line
ZooMAb® learn more
form
lyophilized
mol wt
calculated mol wt 56.21 kDa
species reactivity (predicted by homology)
influenza A virus
packaging
antibody small pack of 25 μL
greener alternative product characteristics
Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.
enhanced validation
recombinant expression
Learn more about Antibody Enhanced Validation
sustainability
Greener Alternative Product
technique(s)
ELISA: suitable, immunocytochemistry: suitable
isotype
IgG2a
epitope sequence
Unknown
UniProt accession no.
greener alternative category
shipped in
ambient
storage temp.
2-8°C
target post-translational modification
unmodified
General description
Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.
Learn more about ZooMAb here.
Immunogen
Application
Evaluated by Immunocytochemistry in MDCK cells infected with Influenza A virus.
Immunocytochemistry Analysis: A 1:100 dilution of this antibody detected Influenza A Nucleoprotein in MDCK cells infected with Influenza A virus.
Tested applications
ELISA Analysis: 1.0 μg/mL from a representative lot detected recombinant Influenza A virus Nucleoprotein.
Affinity Binding Assay: A representative lot of this antibody bound recombinant Influenza A Nucleoprotein with a KD of 2.8 x 10-6 in an affinity binding assay.
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Biochem/physiol Actions
Physical form
Preparation Note
Legal Information
Disclaimer
1 of 1
Tato položka | |||
|---|---|---|---|
| conjugate unconjugated | conjugate unconjugated | conjugate unconjugated | conjugate unconjugated |
| biological source mouse | biological source mouse | biological source mouse | biological source mouse |
| antibody form purified antibody | antibody form purified antibody | antibody form purified antibody | antibody form purified antibody |
| clone A1, recombinant monoclonal | clone 12D10, recombinant monoclonal | clone 133-1H, recombinant monoclonal | clone 6F3.1, recombinant monoclonal |
| form lyophilized | form lyophilized | form lyophilized | form lyophilized |
| isotype IgG2a | isotype IgG2aκ | isotype IgG2aκ | isotype IgG2a |
Still not finding the right product?
Vyzkoušejte náš nástroj Nástroj pro výběr produktů a zúžte své možnosti.
Skladovací třída
11 - Combustible Solids
wgk
WGK 1
Vyberte jednu z posledních verzí:
Již tento produkt vlastníte?
Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.



